Swedish medtech company Getinge announced today that the president of its Life Science business is resigning to pursue an external opportunity. A veteran of BD, Abbott and Boston Scientific, Eric Honroth joined Getinge eight years ago. He moved up to worldwide president of Life Science in 2022. “We are thankful for Eric’s important contributions to…
Getinge launches manual, externally openable port for pharma manufacturing
Getinge recently launched its DPTE-FLEX manual, externally openable port for pharmaceutical manufacturing. The company designed the port to enhance safety, efficiency and compliance. It allows for secure, gloveless transfers to reduce human intervention and contamination risks. “The external handles of the DPTE-FLEX perform dual functions — unlocking/locking and opening/closing – all accessible from outside the…
Getinge to acquire High Purity New England for up to $290M
Getinge announces today that it will purchase High Purity New England, a Smithfield, Rhode Island–based provider of custom single-use products for bioprocessing applications. The Sweden-based life sciences giant will pay SEK 1.3 billion ($120 million)for all of privately-held High Purity New England’s outstanding shares at closing. In addition, there could be a maximum earn out…